Results 121 to 130 of about 54,603 (242)

Alcoholic liver disease: A current molecular and clinical perspective

open access: yesLiver Research, 2018
Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis.
Koichiro Ohashi   +2 more
doaj  

Mitochondrial dysfunction: Related diseases, influencing factors, and detection

open access: yesInterdisciplinary Medicine, EarlyView.
Mitochondrial dysfunction is implicated in the pathogenesis of numerous diseases, including neurological disorders, cancers, and cardiovascular conditions, through mechanisms such as mitochondrial DNA mutations, dysregulation of mitochondrial network dynamics, and impaired mitophagy.
Zhaojin Li   +9 more
wiley   +1 more source

Roles of nanomagnetic beads on biosensing: From fabrication to application

open access: yesInterdisciplinary Medicine, EarlyView.
Leveraging their intrinsic superparamagnetic properties and rapid magnetic responsiveness, functionalized nanomagnetic beads have emerged as pivotal platforms in advanced biosensing system. Through surface engineering and structural design, these magnetic nanoparticles demonstrate multi‐capabilities, such as sample separation, signal enhancement, and ...
Junjie Li   +11 more
wiley   +1 more source

Epigenetic therapy for alcoholic hepatitis: can larsucosterol change the treatment landscape? [PDF]

open access: yesAnn Med Surg (Lond)
Fatima F   +4 more
europepmc   +1 more source

Alcohol and hepatic regeneration

open access: yesGastroenterology, 1980
Peter R. Holt, William O. Frank
openaire   +3 more sources

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis   +5 more
wiley   +1 more source

Parental liver disease mortality is associated with unfavorable outcomes in patients with alcohol-associated hepatitis. [PDF]

open access: yesHepatol Commun
Tu W   +20 more
europepmc   +1 more source

Application of Two‐Dimensional Shear Wave Elastography in Evaluating Liver Reserve Function in Patients With Liver Cancer

open access: yesJournal of Clinical Ultrasound, EarlyView.
ABSTRACT Background Shear wave elastography (SWE) is an emerging noninvasive imaging technique for assessing liver fibrosis. This meta‐analysis aimed to evaluate the diagnostic accuracy of SWE compared to conventional imaging techniques. Methods A systematic search was conducted in PubMed, Embase, Cochrane Library, and Web of Science databases.
Bijuan Hu, Zhiping Huang, Liyin Huang
wiley   +1 more source

Trends in resource utilization for new‐onset psychosis hospitalizations at children's hospitals

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background Children with new‐onset psychosis often require hospitalization for medical evaluation. Objectives The goal of this study was to assess variations in the management of children with new‐onset psychosis and characterize trends in resource utilization.
Ankita Gupta   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy